Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Pleural effusion

From Wikipedia, the free encyclopedia
(Redirected fromHydrothorax)
Accumulation of excess fluid in the pleural cavity
Medical condition
Pleural effusion
Diagram of fluid buildup in the pleura
SpecialtyPulmonology

Apleural effusion is accumulation of excessive fluid in thepleural space, thepotential space that surrounds eachlung.Under normal conditions,pleural fluid is secreted by theparietal pleural capillaries at a rate of 0.6 millilitre per kilogram weight per hour, and is cleared bylymphatic absorption leaving behind only 5–15 millilitres of fluid, which helps to maintain a functionalvacuum between the parietal andvisceral pleurae. Excess fluid within the pleural space can impairinspiration by upsetting the functional vacuum andhydrostatically increasing the resistance against lung expansion, resulting in a fully or partiallycollapsed lung.

Various kinds of fluid can accumulate in the pleural space, such asserous fluid (hydrothorax),blood (hemothorax),pus (pyothorax, more commonly known aspleural empyema),chyle (chylothorax), or very rarelyurine (urinothorax) orfeces (coprothorax).[1] When unspecified, the term "pleural effusion" normally refers to hydrothorax. A pleural effusion can also be compounded by apneumothorax (accumulation ofair in the pleural space), leading to ahydropneumothorax.

Types

[edit]

Various methods can be used to classify pleural fluid.[2]By the origin of the fluid:

By pathophysiology:

Causes

[edit]
Pleural effusion

Transudative

[edit]

The most common causes oftransudative pleural effusion in the United States areheart failure andcirrhosis.Nephrotic syndrome, leading to the loss of large amounts ofalbumin in urine and resultantlow albumin levels in the blood and reduced colloid osmotic pressure, is another less common cause of pleural effusion.Pulmonary emboli were once thought to cause transudative effusions, but have been recently shown to be exudative.[3]The mechanism for the exudative pleural effusion in pulmonary thromboembolism is probably related to increased permeability of thecapillaries in the lung, which results from the release ofcytokines or inflammatory mediators (e.g.vascular endothelial growth factor) from theplatelet-richblood clots. The excessiveinterstitial lung fluid traverses thevisceral pleura and accumulates in thepleural space.[citation needed]

Conditions associated with transudative pleural effusions include:[4]

Exudative

[edit]
Anteroposterior chest X-ray of a pleural effusion. The A arrow shows fluid layering in the right pleural cavity. The B arrow shows the normal width of the lung in the cavity.

When a pleural effusion has been determined to beexudative, additional evaluation is needed to determine its cause, andamylase,glucose,pH and cell counts should be measured.

The most common causes of exudative pleural effusions are bacterialpneumonia, cancer (withlung cancer,breast cancer, andlymphoma causing approximately 75% of all malignant pleural effusions), viral infection, andpulmonary embolism.

Another common cause is after heart surgery when incompletely drained blood can lead to an inflammatory response that causes exudative pleural fluid.

Conditions associated with exudative pleural effusions:[4]

Other/ungrouped

[edit]

Other causes of pleural effusion includetuberculosis (though stains of pleural fluid are only rarely positive foracid-fast bacilli, this is the most common cause of pleural effusions in some developing countries),autoimmune disease such assystemic lupus erythematosus, bleeding (often due to chest trauma),chylothorax (most commonly caused by trauma), and accidental infusion of fluids.[7] Less common causes include esophageal rupture or pancreatic disease, intra-abdominal abscesses,rheumatoid arthritis, asbestos pleural effusion,mesothelioma,Meigs's syndrome (ascites and pleural effusion due to a benignovarian tumor), andovarian hyperstimulation syndrome.[7]

Pleural effusions may also occur throughmedical or surgical interventions, including the use of medications (pleural fluid is usuallyeosinophilic),coronary artery bypass surgery, abdominal surgery,endoscopic variceal sclerotherapy,radiation therapy,liver orlung transplantation, insertion of ventricular shunt as a treatment method of hydrocephalus,[8][9] and intra- or extravascular insertion ofcentral lines.[citation needed]

Pathophysiology

[edit]

Pleural fluid is secreted by the parietal layer of thepleura by way ofbulk flow and reabsorbed by the lymphatics in the most dependent parts of the parietal pleura, primarily the diaphragmatic and mediastinal regions.[10]

Pleural effusion may occur by the following mechanisms: impaired lymphatic drainage of the pleural cavity, fluidtransudation due to decreased plasma colloid osmotic pressure or abnormally high pulmonary and peripheral blood pressure (notably due to heart failure), or due to increased permeability of pleural surfaces (i.e.exudation due to inflammation).[11]

Exudative pleural effusions occur when the pleura is damaged, e.g., by trauma, infection, or malignancy, and transudative pleural effusions develop when there is either excessive production of pleural fluid or the resorption capacity is reduced.[12]

Diagnosis

[edit]
A large left-sided pleural effusion as seen on an upright chest X-ray

A pleural effusion is usually diagnosed on the basis ofmedical history andphysical exam, and confirmed by achest X-ray. Once accumulated fluid is more than 500 mL, there are usually detectableclinical signs, such as decreased movement of the chest on the affected side, dullness to percussion over the fluid, diminishedbreath sounds on the affected side, decreased vocal resonance andfremitus (though this is an inconsistent and unreliable sign), andpleural friction rub. Above the effusion, where the lung is compressed, there may be bronchial breathing sounds andegophony. A large effusion there may causetracheal deviation away from the effusion. A systematic review (2009) published as part of the Rational Clinical Examination Series in theJournal of the American Medical Association showed that dullness to conventional percussion was most accurate for diagnosing pleural effusion (summary positivelikelihood ratio, 8.7; 95%confidence interval, 2.2–33.8), while the absence of reduced tactile vocal fremitus made pleural effusion less likely (negative likelihood ratio, 0.21; 95% confidence interval, 0.12–0.37).[13]

Imaging

[edit]

A pleural effusion appears as an area of whiteness on a standard posteroanterior chest X-ray.[14] Normally, the space between the visceral pleura and the parietal pleura cannot be seen. A pleural effusion infiltrates the space between these layers. Because the pleural effusion has a density similar to water, it can be seen on radiographs. Since the effusion has greater density than the rest of the lung, it gravitates towards the lower portions of thepleural cavity. The pleural effusion behaves according to basic fluid dynamics, conforming to the shape of pleural space, which is determined by the lung and chest wall. If the pleural space contains both air and fluid, then an air-fluid level that is horizontal will be present, instead of conforming to the lung space.[15] Chest radiographs in the lateraldecubitus position (with the patient lying on the side of the pleural effusion) are more sensitive and can detect as little as 50 mL of fluid. Between 250 and 600mL of fluid must be present before upright chest X-rays can detect a pleural effusion (e.g., bluntedcostophrenic angles).[16]

Chestcomputed tomography is more accurate for diagnosis and may be obtained to better characterize the presence, size, and characteristics of a pleural effusion. Lungultrasound, nearly as accurate as CT and more accurate than chest X-ray, is increasingly being used at the point of care to diagnose pleural effusions, with the advantage that it is a safe, dynamic, and repeatable imaging modality.[17] To increase diagnostic accuracy of detection of pleural effusion sonographically, markers such as boomerang and VIP signs can be utilized.[18]

  • Massive left-sided pleural effusion (whiteness) in a patient presenting with lung cancer
    Massive left-sided pleural effusion (whiteness) in a patient presenting with lung cancer
  • CT scan of the chest showing a left-sided pleural effusion. The fluid usually settles at the lowest space due to gravity; in this case, at the back because the patient is supine.
    CT scan of the chest showing a left-sided pleural effusion. The fluid usually settles at the lowest space due togravity; in this case, at the back because the patient is supine.
  • The lung expanding within an area of pleural effusion as seen by ultrasound
  • Micrograph of a pleural fluid cytopathology specimen showing malignant mesothelioma, one cause of a pleural effusion
    Micrograph of a pleural fluidcytopathology specimen showingmalignant mesothelioma, one cause of a pleural effusion
  • A pleural effusion as seen on lateral upright chest x-ray
    A pleural effusion as seen on lateral upright chest x-ray
  • Pleural effusion as seen behind the heart[19]
  • Massive pleural effusion, later proven to be hemothorax, in a South Indian male
    Massive pleural effusion, later proven to be hemothorax, in a South Indian male

Thoracentesis

[edit]

Once a pleural effusion is diagnosed, its cause must be determined. Pleural fluid is drawn out of the pleural space in a process calledthoracentesis, and it should be done in almost all patients who have pleural fluid that is at least 10 mm in thickness on CT, ultrasonography, or lateral decubitus X-ray and that is new or of uncertain etiology. In general, the only patients who do not require thoracentesis are those who haveheart failure with symmetric pleural effusions and no chest pain or fever; in these patients,diuresis can be tried, and thoracentesis is avoided unless effusions persist for more than 3 days.[20] In a thoracentesis, a needle is inserted through the back of the chest wall in the sixth, seventh, or eighth intercostal space on the midaxillary line, into the pleural space. The use ofultrasound to guide the procedure is now standard of care as it increases accuracy and decreases complications.[21][22] After removal, the fluid may then be evaluated for:

  1. Chemical composition includingprotein,lactate dehydrogenase (LDH),albumin,amylase,pH, andglucose
  2. Gram stain and culture to identify possible bacterial infections
  3. White andred blood cell counts and differential white blood cell counts
  4. Cytopathology to identify cancer cells, but may also identify some infective organisms
  5. Other tests as suggested by the clinical situation –lipids,fungal culture,viral culture, tuberculosis cultures, lupus cell prep, specificimmunoglobulins

Light's criteria

[edit]
Transudate vs.exudate
TransudateExudate
Main causeshydrostatic
pressure
,
colloid
osmotic pressure
Inflammation, increased
vascular permeability
AppearanceClear[23]Cloudy[23]
Specific gravity< 1.012> 1.020
Protein content< 2.5 g/dL> 2.9 g/dL[24]
fluid [protein]
serum [protein]
< 0.5> 0.5[25]
SAAG =
serum [albumin] − fluid [albumin]
> 1.2 g/dL< 1.2 g/dL[26]
fluidLDH
upper limit for serum
< 0.6 or <23> 0.6[24] or >23[25]
Cholesterol content< 45 mg/dL> 45 mg/dL
Radiodensity onCT scan2 to 15HU[27]4 to 33HU[27]
Instruments for needle biopsy of the pleura[28]

Definitions of the terms "transudate" and "exudate" are the source of much confusion. Briefly, transudate is produced through pressure filtration without capillary injury while exudate is "inflammatory fluid" leaking between cells.[29]

Transudative pleural effusions are defined as effusions that are caused bysystemic factors that alter the pleural equilibrium, orStarling forces. The components of the Starling forces – hydrostatic pressure, permeability, and oncotic pressure (effective pressure due to the composition of the pleural fluid and blood) – are altered in many diseases, e.g.,left ventricular failure, kidney failure, liver failure, andcirrhosis. Exudative pleural effusions, by contrast, are caused by alterations inlocal factors that influence the formation and absorption of pleural fluid (e.g.,bacterial pneumonia,cancer,pulmonary embolism, and viral infection).[30]

An accurate diagnosis of the cause of the effusion, transudate versus exudate, relies on a comparison of the chemistries in the pleural fluid to those in the blood, using Light's criteria. According to Light's criteria (Light, et al. 1972), a pleural effusion is likely exudative if at least one of the following exists:[31]

  1. The ratio of pleural fluid protein to serum protein is greater than 0.5
  2. The ratio of pleural fluid LDH and serum LDH is greater than 0.6
  3. Pleural fluid LDH is greater than 0.6[24] or23[31] times the normal upper limit for serum. Different laboratories have different values for the upper limit of serum LDH, but examples include 200[32] and 300[32]IU/l.[33]

The sensitivity and specificity of Light's criteria for detection of exudates have been measured in many studies and are usually reported to be around 98% and 80%, respectively.[34][35] This means that although Light's criteria are relatively accurate, twenty percent of patients that are identified by Light's criteria as having exudative pleural effusions actually have transudative pleural effusions. Therefore, if a patient identified by Light's criteria as having an exudative pleural effusion appears clinically to have a condition that usually produces transudative effusions, additional testing is needed. In such cases,albumin levels in blood and pleural fluid are measured. If the difference between the albumin level in the blood and the pleural fluid is greater than 1.2 g/dL (12 g/L), this suggests that the patient has a transudative pleural effusion.[26] However, pleural fluid testing is not perfect, and the final decision about whether a fluid is a transudate or an exudate is based not on chemical analysis of the fluid, but an accurate diagnosis of the disease that produces the fluid.[29]

The traditional definitions of transudate as a pleural effusion due to systemic factors and an exudate as a pleural effusion due to local factors have been used since 1940 or earlier (Light et al., 1972). Previous to Light's landmark study, which was based on work by Chandrasekhar, investigators unsuccessfully attempted to use other criteria, such as specific gravity, pH, and protein content of the fluid, to differentiate between transudates and exudates. Light's criteria are highly statistically sensitive for exudates (although not very statistically specific). More recent studies have examined other characteristics of pleural fluid that may help to determine whether the process producing the effusion is local (exudate) or systemic (transudate). The table above illustrates some of the results of these more recent studies. However, it should be borne in mind that Light's criteria are still the most widely used criteria.[citation needed]

The Rational Clinical Examination Series review found that bilateral effusions, symmetric and asymmetric, are the most common distribution in heart failure (60% of effusions in heart failure will be bilateral). When there is asymmetry in heart failure-associated pleural effusions (either unilateral or one side larger than the other), the right side is usually more involved than the left.[13]

The instruments pictured are accurately shaped, however, most hospitals now use safer disposabletrocars. Because these are single use, they are always sharp and have a much smaller risk of cross patient contamination.[citation needed]

Medical condition
Hydrothorax
SpecialtyPulmology

Hydrothorax

[edit]

Hydrothorax is the synonym of pleural effusion in which fluid accumulates in thepleural cavity. This condition is most likely to develop secondary tocongestive heart failure, following an increase in hydrostatic pressure within the lungs. More rarely, hydrothorax can develop in 10% of patients withascites which is calledhepatic hydrothorax. It is often difficult to manage inend-stage liver failure and often fails to respond to therapy.[36]

Treatment of hydrothorax is difficult for several reasons. The underlying condition needs to be corrected; however, often the source of the hydrothorax is end-stage liver disease and correctable only by transplant. Chest tube placement should not occur. Other measures such as aTIPS procedure are more effective as they treat the cause of the hydrothorax, but have complications such as worsened hepatic encephalopathy.[37]

Treatment

[edit]

Treatment depends on the underlying cause of the pleural effusion.

Therapeutic aspiration may be sufficient; larger effusions may require insertion of anintercostal drain (either pigtail or surgical). When managing these chest tubes, it is important to make sure the chest tubes do not become occluded or clogged. A clogged chest tube in the setting of continued production of fluid will result in residual fluid left behind when the chest tube is removed. This fluid can lead to complications such ashypoxia due tolung collapse from the fluid, orfibrothorax if scarring occurs. Repeated effusions may require chemical (talc,bleomycin,tetracycline/doxycycline), or surgicalpleurodesis, in which the two pleural surfaces are scarred to each other so that no fluid can accumulate between them. This is a surgical procedure that involves inserting a chest tube, then either mechanically abrading the pleura or inserting the chemicals to induce a scar. This requires the chest tube to stay in until the fluid drainage stops. This can take days to weeks and can require prolonged hospitalizations. If the chest tube becomes clogged, fluid will be left behind and thepleurodesis will fail.[citation needed]

Pleurodesis fails in as many as 30% of cases. An alternative is to place a PleurX Pleural Catheter or Aspira Drainage Catheter. This is a 15Fr chest tube with a one-way valve. Each day the patient or caregivers connect it to a simple vacuum tube and remove from 600 to 1000 mL of fluid, and can be repeated daily. When not in use, the tube is capped. This allows patients to be outside the hospital. For patients withmalignant pleural effusions, it allows them to continue chemotherapy if indicated. Generally, the tube is in for about 30 days, and then it is removed when space undergoes spontaneous pleurodesis.

Tubercular pleural effusion is one of the common extrapulmonary forms of tuberculosis. Treatment consists of antituberculosis treatment (ATT). The currently recommended ATT regime is two months of isoniazid, rifampicin, ethambutol and pyrazinamide followed by four months of isoniazid, rifampicin and ethambutol.[38]

See also

[edit]

References

[edit]
  1. ^Shore, D.; Malhotra, A. (May 2018)."Coprothorax: A Feculent Pleura".C54. Critical Care Case Reports: Causes and Complications of Acute Respiratory Failure. American Thoracic Society International Conference Abstracts. American Thoracic Society.doi:10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A5333 (inactive 27 September 2025).{{cite book}}: CS1 maint: DOI inactive as of September 2025 (link)
  2. ^"Pleural effusion".U.S. National Library of Medicine. Retrieved2 July 2021.
  3. ^Porcel, José M; Light, Richard W (July 2008). "Pleural effusions due to pulmonary embolism".Current Opinion in Pulmonary Medicine.14 (4):337–342.doi:10.1097/MCP.0b013e3282fcea3c.PMID 18520269.
  4. ^abGalagan et al. Color Atlas of Body Fluids. CAP Press, Northfield, 2006
  5. ^"Atelectasis".The Lecturio Medical Concept Library. Retrieved2 July 2021.
  6. ^de Menezes Lyra R (July 1997)."A modified outer cannula can help thoracentesis after pleural biopsy"(PDF).Chest.112 (1): 296.doi:10.1378/chest.112.1.296.PMID 9228404.[permanent dead link]
  7. ^abJany, B; Welte, T (May 2019)."Pleural Effusion in Adults—Etiology, Diagnosis, and Treatment".Deutsches Ärzteblatt International.116 (21):377–386.doi:10.3238/arztebl.2019.0377.PMC 6647819.PMID 31315808.
  8. ^Gupta, A. K.; Berry, M. (April 1994). "Ventriculo-peritoneal shunt presenting with recurrent pleural effusion: Report of a new complication".Pediatric Radiology.24 (2): 147.doi:10.1007/BF02020178.PMID 8078722.
  9. ^Raicevic Mirjana, Nikolovski Srdjan, Golubovic Emilija. Pleural Effusion as a Ventriculo-Peritoneal Shunt Complication in Children (Meeting Abstract). Acta Med Acad. 2019;48(S1):26.
  10. ^D'Agostino, Horacio P.; Edens, Mary Ann (2024),"Physiology, Pleural Fluid",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 30020725, retrieved2024-07-15
  11. ^Hall, John E.; Hall, Michael E. (2021). "Chapter 39 - Pulmonary Circulation, Pulmonary Edema, and Pleural Fluid".Guyton and Hall Textbook of Medical Physiology (14th ed.). Philadelphia, PA: Elsevier. p. 487.ISBN 978-0-323-59712-8.
  12. ^Porcel, José M.; Light, Richard W. (1 April 2006)."Diagnostic approach to pleural effusion in adults".American Family Physician.73 (7):1211–1220.PMID 16623208.
  13. ^abWong CL, Holroyd-Leduc J, Straus SE (Jan 2009). "Does this patient have a pleural effusion?".JAMA.301 (3):309–17.doi:10.1001/jama.2008.937.PMID 19155458.
  14. ^Corne; et al. (2002).Chest X-Ray Made Easy. Churchill Livingstone.ISBN 0-443-07008-3.
  15. ^Squire, Lucy Frank; Novelline, Robert A. (2004).Squire's fundamentals of radiology. Cambridge: Harvard University Press. pp. 132–3.ISBN 0-674-01279-8.
  16. ^Bell DJ, Jones J (May 2009)."Pleural effusion".Radiopaedia. RetrievedJuly 20, 2021.
  17. ^Volpicelli, Giovanni; Elbarbary, Mahmoud; Blaivas, Michael; Lichtenstein, Daniel A.; Mathis, Gebhard; Kirkpatrick, Andrew W.; Melniker, Lawrence; Gargani, Luna; Noble, Vicki E.; Via, Gabriele; Dean, Anthony; Tsung, James W.; Soldati, Gino; Copetti, Roberto; Bouhemad, Belaid; Reissig, Angelika; Agricola, Eustachio; Rouby, Jean-Jacques; Arbelot, Charlotte; Liteplo, Andrew; Sargsyan, Ashot; Silva, Fernando; Hoppmann, Richard; Breitkreutz, Raoul; Seibel, Armin; Neri, Luca; Storti, Enrico; Petrovic, Tomislav (April 2012)."International evidence-based recommendations for point-of-care lung ultrasound".Intensive Care Medicine.38 (4):577–591.doi:10.1007/s00134-012-2513-4.PMID 22392031.
  18. ^Lau, James Siu Ki; Yuen, Chi Kit; Mok, Ka Leung; Yan, Wing Wa; Kan, Pui Gay (July 2018). "Visualization of the inferoposterior thoracic wall (VIP) and boomerang signs-novel sonographic signs of right pleural effusion".The American Journal of Emergency Medicine.36 (7):1134–1138.doi:10.1016/j.ajem.2017.11.023.PMID 29162443.
  19. ^"UOTW #23 - Ultrasound of the Week".Ultrasound of the Week. 22 October 2014. Retrieved27 May 2017.
  20. ^Light, Richard W."Pleural Effusion".Merck Manual for Health Care Professionals. Merck Sharp & Dohme Corp. Retrieved21 August 2013.
  21. ^Feller-Kopman, David (July 2007). "Therapeutic thoracentesis: the role of ultrasound and pleural manometry".Current Opinion in Pulmonary Medicine.13 (4):312–318.doi:10.1097/MCP.0b013e3281214492.PMID 17534178.
  22. ^Gordon, Craig E.; Feller-Kopman, D; Balk, EM; Smetana, GW (22 February 2010). "Pneumothorax Following Thoracentesis: A Systematic Review and Meta-analysis".Archives of Internal Medicine.170 (4):332–339.doi:10.1001/archinternmed.2009.548.PMID 20177035.
  23. ^abThe University of Utah • Spencer S. Eccles Health Sciences Library > WebPath images >"Inflammation".
  24. ^abcHeffner J, Brown L, Barbieri C (1997). "Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Primary Study Investigators".Chest.111 (4):970–80.doi:10.1378/chest.111.4.970.PMID 9106577.
  25. ^abLight R, Macgregor M, Luchsinger P, Ball W (1972). "Pleural effusions: the diagnostic separation of transudates and exudates".Ann Intern Med.77 (4):507–13.doi:10.7326/0003-4819-77-4-507.PMID 4642731.
  26. ^abRoth BJ, O'Meara TF, Gragun WH (1990). "The serum-effusion albumin gradient in the evaluation of pleural effusions".Chest.98 (3):546–9.doi:10.1378/chest.98.3.546.PMID 2152757.
  27. ^abCullu, Nesat; Kalemci, Serdar; Karakas, Omer; Eser, Irfan; Yalcin, Funda; Boyaci, Fatma Nurefsan; Karakas, Ekrem (2013)."Efficacy of CT in diagnosis of transudates and exudates in patients with pleural effusion".Diagnostic and Interventional Radiology.20:116–20.doi:10.5152/dir.2013.13066.ISSN 1305-3825.PMC 4463296.PMID 24100060.
  28. ^de Menezes Lyra R (1997). "A modified outer cannula can help thoracentesis after pleural biopsy".Chest.112 (1): 296.doi:10.1378/chest.112.1.296.PMID 9228404.
  29. ^abLight RW, Macgregor MI, Luchsinger PC, Ball WC Jr (October 1972). "Pleural effusions: the diagnostic separation of transudates and exudates".Annals of Internal Medicine.77 (4):507–13.doi:10.7326/0003-4819-77-4-507.PMID 4642731.
  30. ^Light, Richard W. (2008). "Disorders of the Pleura and Mediastinum". In Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J (eds.).Harrison's Principles of Internal Medicine (17th ed.). McGraw Hill Professional.ISBN 978-0-07-164114-2.
  31. ^abLight, Richard W.; Macgregor, M. Isabelle; Luchsinger, Peter C.; Ball, Wilmot C. (October 1972). "Pleural Effusions: The Diagnostic Separation of Transudates and Exudates".Annals of Internal Medicine.77 (4):507–513.doi:10.7326/0003-4819-77-4-507.PMID 4642731.
  32. ^abJoseph J, Badrinath P, Basran GS, Sahn SA (November 2001)."Is the pleural fluid transudate or exudate? A revisit of the diagnostic criteria".Thorax.56 (11):867–70.doi:10.1136/thorax.56.11.867.PMC 1745948.PMID 11641512.
  33. ^Joseph J, Badrinath P, Basran GS, Sahn SA (2002)."Is albumin gradient or fluid to serum albumin ratio better than the pleural fluid lactate dehydroginase in the diagnostic of separation of pleural effusion?".BMC Pulmonary Medicine.2 1.doi:10.1186/1471-2466-2-1.PMC 101409.PMID 11914151.
  34. ^Romero, Santiago; Martinez, Adela; Hernandez, Luis; Fernandez, Cleofe; Espasa, Antonia; Candela, Alfredo; Martin, Concepcion (2000). "Light's Criteria Revisited: Consistency and Comparison with New Proposed Alternative Criteria for Separating Pleural Transudates from Exudates".Respiration.67 (1):18–23.doi:10.1159/000029457.PMID 10705257.
  35. ^Porcel, José M.; Peña, José M.; Vicente de Vera, Carmina; Esquerda, Aureli (February 2006). "Revaluación del método estándar (criterios de Light) para identificar exudados pleurales" [Reappraisal of the standard method (Light's criteria) for identifying pleural exudates].Medicina Clínica (in Spanish).126 (6):211–213.doi:10.1157/13084870.PMID 16510093.
  36. ^Korenblat, Kevin (2017). "Management of ascites in cirrhosis and portal hypertension".Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. pp. 1189–1195.e2.doi:10.1016/B978-0-323-34062-5.00081-9.ISBN 978-0-323-34062-5.
  37. ^Garbuzenko, Dmitry Victorovich; Arefyev, Nikolay Olegovich (8 November 2017)."Hepatic hydrothorax: An update and review of the literature".World Journal of Hepatology.9 (31):1197–1204.doi:10.4254/wjh.v9.i31.1197.PMC 5680207.PMID 29152039.
  38. ^"Recommendations".WHO consolidated guidelines on tuberculosis: Module 3: Diagnosis – Rapid diagnostics for tuberculosis detection. World Health Organization. 2024.ISBN 978-92-4-008948-8.

External links

[edit]
Classification
External resources
Upper RT
(includingURTIs,
common cold)
Head
Neck
Lower RT/
lung disease
(includingLRTIs)
Bronchial/
obstructive
Interstitial/
restrictive
(fibrosis)
External agents/
occupational
lung disease
Other
Obstructive /
Restrictive
Pneumonia/
pneumonitis
By pathogen
By vector/route
By distribution
IIP
Other
Pleural cavity/
mediastinum
Pleural disease
Mediastinal disease
Other/general
Authority control databases: NationalEdit this at Wikidata
Retrieved from "https://en.wikipedia.org/w/index.php?title=Pleural_effusion&oldid=1319165367#Hydrothorax"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp